XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities:    
Net income $ 2,826,969 $ 211,721
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,861,710 1,559,641
Amortization of deferred financing costs and debt discount as interest (18,437) (4,942)
Amortization of key money loans (26,750) (30,029)
Gain on loan extinguishment (942,605) (635,317)
Gain on interest rate cap/swap (85,109) (203,251)
Changes in operating assets and liabilities:    
Accounts receivable (319,029) (229,060)
Due from related parties (982,799) (99,732)
Prepaid expenses and other assets (279,686) (1,639,179)
Accounts payable, accrued expenses and other 1,308,400 1,723,825
Due to related parties 825,337 831,938
Net cash provided by operating activities 4,168,001 1,485,615
Cash Flows from Investing Activities:    
Loan receivable funding   (7,689,594)
Capital improvements (1,853,035) (307,799)
Net cash used in investing activities (1,853,035) (7,997,393)
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock   6,691,279
Payment of commissions and dealer manager fees and stockholder servicing fees (2,869) (359,262)
Payment of other offering costs to affiliates   (522,659)
Proceeds from mortgage note 939,181  
Proceeds from other debt   1,426,672
Payments of mortgage notes principal (209,809) (200,922)
Distributions to stockholders (1,505,235)  
Distributions to noncontrolling interest (477,750) (591,430)
Repurchase of common stock (454,083) (297,341)
Net cash (used in) provided by financing activities (1,710,565) 6,146,337
Increase (decrease) in cash and cash equivalents and restricted cash 604,401 (365,441)
Cash and cash equivalents and restricted cash, beginning of period 9,838,402 10,269,947
Cash and cash equivalents and restricted cash, end of period $ 10,442,803 $ 9,904,506